Häufigkeit und Vorkommen multiresistenter gramnegativer Erreger: 3MRGN/4MRGN

Abstract

The increase of multidrug-resistant Gram-negative bacilli (MRGN) is a great threat for both the health system and patients. Challenges of MRGN for physicians are limited therapeutic options, the need of infection control measures and the danger of outbreaks. In this article, the prevalence of MRGN, risk factors, the background and definitions of multidrug-resistant organisms are presented.

Das zunehmende Auftreten multiresistenter gramnegativer Bakterien (MRGN) konfrontiert Krankenhäuser mit eingeschränkten Therapiemöglichkeiten, aufwendigen Hygienemaßnahmen und der Gefahr von Ausbrüchen. Für ein effektives Screening ist es wichtig, Risikofaktoren und lokale Resistenzraten zu kennen und zu berücksichtigen. Dieser Artikel gibt einen Überblick über Häufigkeiten, Risikofaktoren und die komplexen Begrifflichkeiten bei MRGN.

Schlüsselwörter

ESBL - Carbapenemase - MRGN - MRGN - CPE - CRE

Key words

ESBL - carbapenemase - MRGN - CPE - CRE

• Literatur

• 1 Robert Koch Institut (RKI). ARS – Antibiotika-Resistenz-Surveillance. https://ars.rki.de/Content/Database/ResistanceDevelopment.aspx , letzter Aufruf 03.04.2018
• 2 Magiorakos AP, Srinivasan A, Carey RB. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012; 18: 268-281 . doi:10.1111/j.1469-0691.2011.03570.x
• 3 Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO). Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012: 1311-1354
• 4 Tacconelli E, Cataldo MA, Dancer SJ. et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2014; 20 (Suppl. 01) 1-55 . doi:10.1111/1469-0691.12427
• 5 Pfennigwerth N. Bericht des NRZ für gramnegative Krankenhauserreger. Epid Bull 2017; 25: 229-233 . doi:10.17886/EpiBull-2017-034.2
• 6 Göttig S, Gruber TM, Stecher B. et al. In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2015; 60: 1808-1815 . doi:10.1093/cid/civ191
• 7 Gruber TM, Gottig S, Mark L. et al. Pathogenicity of pan-drug-resistant Serratia marcescens harbouring blaNDM-1. The Journal of antimicrobial chemotherapy 2015; 70: 1026-1030 . doi:10.1093/jac/dku482
• 8 Bar-Yoseph H, Hussein K, Braun E. et al. Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy 2016; 71: 2729-2739 . doi:10.1093/jac/dkw221
• 9 Falagas ME, Lourida P, Poulikakos P. et al. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother 2014; 58: 654-663
• 10 Tumbarello M, Viale P, Viscoli C. et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2012; 55: 943-950 . doi:10.1093/cid/cis588
• 11 Valenza G, Nickel S, Pfeifer Y. et al. Extended-spectrum-beta-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrobial agents and chemotherapy 2014; 58: 1228-1230 . doi:10.1128/AAC.01993-13
• 12 Hamprecht A, Rohde AM, Behnke M. et al. Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. The Journal of antimicrobial chemotherapy 2016; 71: 2957-2963 . doi:10.1093/jac/dkw216
• 13 Jazmati N, Hein R, Hamprecht A. Use of an Enrichment Broth Improves Detection of Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae in Clinical Stool Samples. Journal of clinical microbiology 2016; 54: 467-470 . doi:10.1128/JCM.02926-15
• 14 Leistner R, Meyer E, Gastmeier P. et al. Risk factors associated with the community-acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia Coli. an exploratory case-control study. PloS one 2013; 8: e74323 . doi:10.1371/journal.pone.0074323
• 15 Kuenzli E, Jaeger VK, Frei R. et al. High colonization rates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC infectious diseases 2014; 14: 528 . doi:10.1186/1471-2334-14-528
• 16 Vehreschild MJ, Hamprecht A, Peterson L. et al. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies. The Journal of antimicrobial chemotherapy 2014; 69: 3387-3392 . doi:10.1093/jac/dku305
• 17 Robert Koch Institut. Stellungnahme des Robert Koch-Instituts zur Frage des Screenings von Asylsuchenden auf Multiresistente Erreger (MRE). 2016: 1-6 https://www.rki.de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/GesundAZ/Content/A/Asylsuchende/Inhalt/MRE-Screening_Asylsuchende.html , letzter Aufruf 03.04.2018
• 18 European Centre for Disease Prevention and Control (ECDC). Surveillance of antimicrobial resistance in Europe 2016. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017: 1-87 . doi:10.2900/296939